Publications
Listed below are publications of
work that use Invitron's
diabetes test kits.
Click on the links to view the abstract and
download information.
Luzio SD, Lucas I, Owens DR.
Importance of validation of
immunoassays for intact proinsulin. Clin Chem Lab Med. 2001; 39(7):
631-633.
> View abstract
Butter NL, Hattersley AT, Clark
PM. Development of a bloodspot
assay for insulin. Clin Chim Acta. 2001; 310: 141-150.
> View abstract
Cozma LS, Luzio SD, Dunseath GJ,
Langendorg KW, Pieber T,
Owens DR. Comparison of the effects of three insulinotropic drugs on
plasma insulin levels after a standard meal. Diabetes Care 2002; 25:
1271-1276.
> View abstract
Pfützner A, Kunt T,
Langenfeld M, Löbig M, Knesovic
M, Forst T. Clinical and laboratory evaluation of specific
chemiluminescence assays for intact and total proinsulin. Clin Chem Lab
Med. 2003;41(9):1234-8.
> View abstract
Pfützner A, Langenfeld M,
Kunt T, Löbig M, Forst T.
Evaluation of human resistin assays with serum from patients with type
2 diabetes and different degrees of insulin resistance. Clin Lab.
2003;49(11-12):571-6.
> View abstract
Pfützner A, Kunt T, Hohberg
C, Mondok A, Pahler S,
Konrad T, Lübben G, Forst T. Fasting intact proinsulin is a highly
specific predictor of insulin resistance in type 2 diabetes. Diabetes
Care. 2004;27(3):682-7.
>
View abstract
Pfützner A, Kann PH,
Pfützner AH, Kunt T, Larbig M,
Weber MM, Forst T. Intact and total proinsulin: new aspects for
diagnosis and treatment of type 2 diabetes mellitus and insulin
resistance. Clin Lab. 2004;50(9-10):567-73.
>
View abstract
Pfützner A, Forst T.
Intaktes Proinsulin als
kardiovaskulärer Risikofaktor und prädikativer diagnostischer
Marker für die Insulinresistenz bei Patienten mit Diabetes Typ 2.
Diabetes u Stoffwechsel 2004; 13: 193-200.
Langenfeld MR, Forst T, Standl E, Strotmann H-J, Lübben
G, Pahler S, Kann P, Pfützner A. IRIS II Study: Sensitivity and
Specificity of Intact Proinsulin, Adiponectin, and the
Proinsulin/Adiponectin Ratio as Markers for Insulin Resistance.
Diabetes Technol Ther. 2004;6(6):836-43.
>
View abstract
Peter R, Luzio SD, Dunseath G,
Miles A, Hare B, Backx k,
Pauvaday V, Owens DR. Effects of exercise on the absorption of insulin
glargine in patients with type 1 diabetes. Diabetes Care 2005; 28:
560-565.
>
View abstract
Pfützner A, Standl E,
Hohberg C, Strotmann HJ,
Lübben G, Langenfeld MR, Schulze J, Forst T. IRIS II Study: Intact
proinsulin is confirmed as a highly specific indicator for insulin
resistance in a large cross-sectional study design. Diabetes Technol
Ther. 2005; 7(3): 478-486.
>
View abstract
Cozma LS, Luzio SD, Dunseath GJ,
Underwood PM, Owens DR.
β-cell response during a test meal: a comparative study of incremental
doses of repaglinide in type 2 diabetic patients. Diabetes Care 2005;
28: 1001-1007.
>
View abstract
Shields BM, Knight B, Shakespeare
L, Babrah J, Powell RJ,
Clark PM, Hattersley AT. Determinants of insulin concentrations in
healthy 1-week-old babies in the community: Applications of a bloodspot
assay. Early Human Development 2006; 82: 143-148.
>
View abstract